ID: ALA3683745

Max Phase: Preclinical

Molecular Formula: C27H23F4N5O5

Molecular Weight: 573.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(OC(C)C#N)cc12

Standard InChI:  InChI=1S/C27H23F4N5O5/c1-13(11-32)40-16-6-7-19-17(10-16)25(14(2)37)34-35(19)12-23(38)36-20-8-15(20)9-21(36)26(39)33-18-4-3-5-22(24(18)28)41-27(29,30)31/h3-7,10,13,15,20-21H,8-9,12H2,1-2H3,(H,33,39)/t13?,15-,20-,21+/m1/s1

Standard InChI Key:  UVXHAQOQYMGHHJ-IKHAONBBSA-N

Associated Targets(Human)

Complement factor D 1353 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 573.50Molecular Weight (Monoisotopic): 573.1635AlogP: 4.20#Rotatable Bonds: 8
Polar Surface Area: 126.55Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.27CX Basic pKa: CX LogP: 3.48CX LogD: 3.48
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.32Np Likeness Score: -1.22

References

1.  (2015)  Complement pathway modulators and uses thereof, 

Source

Source(1):